4-6 April 2024 in Cambridge
We are pleased to announce that the 6th meeting of the European Incretin Study Group will be held in Cambridge, UK, on 4 – 6 April 2024.
The meeting will host 150-180 scientists from academia and industry working in the field of incretin research, spanning all career levels from postgraduate students to clinicians and senior researchers, and spanning the spectrum from basic science, physiology and pathophysiology to diagnostics and clinical applications. Through a packed two-day agenda, we will discuss and disseminate recent advances in incretin-related research, foster networking and collaborations, and promote active participation and presentations from scientists at all levels.
Mirroring the popular structure of previous European Incretin Study Group meetings, the scientific programme will be constructed from the abstracts submitted, including around 40 short oral presentations and dedicated sessions for posters.
The venue for the scientific sessions will be the conference facilities of AstraZeneca’s Discovery Centre (DISC), located on the Cambridge Biomedical Campus. Accommodation and Dinner will be arranged at one of the Cambridge Colleges in the city centre.
Further announcements and call for abstracts will follow later in 2023.
We look forward to seeing you there.
Professors Fiona Gribble and Frank Reimann